Fed. Circ. Affirms Patent Extension For Levaquin
A federal appeals court has upheld a two-year patent extension and accompanying injunction against infringement awarded to Japanese drugmaker Daiichi Pharmaceutical Co. for its antibiotic Levaquin, striking down Lupin Pharmaceuticals Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article